pharmamed usa inc
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for pharmamed usa inc from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 7 transactions, with a transaction quantity of 13.24 and a transaction weight of 13.24.
- Year Transactions Quantity Weight
- 2025 52 1234.37 100.97
- 2026 7 13.24 13.24
Bill of lading data
< 1/15 >- Trade date 2026/01/30 B/L No. 91003048829783
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 3kg Amount 298.49
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 32601753 PEDIDO TRAMITE: OC 051 DECLARACION(1-1) REGISTRO DE IMPORTACION NO: REG-50014751-20260123N, CON FECHA 2026-0 Expand
- Trade date 2026/01/28 B/L No. 91003048807186
- Suppliers pharmamed usa inc Buyers suma activa s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 5.58kg Amount 352
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:2026-00719, PEDIDO 019-26, DECLARACION 1 DE 1, FACTURA(S) 30691, 22 OTRAS, PRODUCTO: CLORURO DE POTASIO MEDICAMENT Expand
- Trade date 2026/01/13 B/L No. 91003048567709
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 1.97kg Amount 345.37
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 32600579 DECLARACION(1-5) REGISTRO DE IMPORTACION NO: REG-50001163-20260105N CON FECHA DE APROBACION 2026-01-05 VIST Expand
- Trade date 2026/01/13 B/L No. 91003048567730
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 0.88kg Amount 153.28
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 32600579 DECLARACION(5-5) REGISTRO DE IMPORTACION NO: REG-50000470-20260102N CON FECHA DE APROBACION 2026-01-02 VIS Expand
- Trade date 2026/01/13 B/L No. 91003048567723
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 0.47kg Amount 81.75
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 32600579 DECLARACION(4-5) REGISTRO DE IMPORTACION NO: REG-50002287-20260106N CON FECHA DE APROBACION 2026-01-06 VIST Expand
- Trade date 2026/01/13 B/L No. 91003048567690
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 0.41kg Amount 71.53
- Hs code 3004391900 Product tags medicaments
- Product description DO 32600579 DECLARACION(2-5) REGISTRO DE IMPORTACION NO: REG-50247648-20251231N CON FECHA DE APROBACION 2025-12-31 VIS Expand
- Trade date 2026/01/13 B/L No. 91003048567834
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 0.93kg Amount 162.48
- Hs code 3004391900 Product tags medicaments
- Product description DO 32600579 DECLARACION(3-5) REGISTRO DE IMPORTACION NO: REG-50002285-20260106N CON FECHA DE APROBACION 2026-01-06 VIST Expand
- Trade date 2025/12/29 B/L No. 91003048404363
- Suppliers pharmamed usa inc Buyers suma activa s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 0.36kg Amount 135
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:2025-10188, PEDIDO 246-25, DECLARACION 1 DE 1, FACTURA(S) 30255, LOTE A1011577 VENCE 052027 3 OTRAS, PRODUCTO: ME Expand
- Trade date 2025/12/24 B/L No. 25nboim414579828
- Suppliers pharmamed usa inc Buyers ripple pharmaceuticals ltd.
- POLs —— PODs ——
- Supply area United States Purchas area Kenya
- Weight —— Amount 4813.999962
- Hs code 30041000 Product tags smo,pro,s30,tablet,e liquid
- Product description PEPTO BISMOL CHEWTAB ORIG 48CT PROCTER GABLE LIQUID ORIG 4OZ CHEW TABLETS30CT UD; PEPTO BISMOL; CT; 880; N; N; 400; H; 1; Expand
- Trade date 2025/12/24 B/L No. 25nboim414579828
- Suppliers pharmamed usa inc Buyers ripple pharmaceuticals ltd.
- POLs —— PODs ——
- Supply area United States Purchas area Kenya
- Weight —— Amount 1090.000024
- Hs code 29225000 Product tags pharm,ok,arm,a me,phenylephrine hcl
- Product description PHENYLEPHRINE HCL 10MG SDV25X1ML ARMS; PHARMA MED; CT; 5; OK; 50; 1; Expand
- Trade date 2025/12/24 B/L No. 25nboim414579828
- Suppliers pharmamed usa inc Buyers ripple pharmaceuticals ltd.
- POLs —— PODs ——
- Supply area United States Purchas area Kenya
- Weight —— Amount 2553.750014
- Hs code 30049000 Product tags dexamethasone
- Product description DEXAMETHASONE 2MG TAB100; DEXAMETHASONE 2MG; CT; 45; N; N; 150; H; 1; Expand
- Trade date 2025/11/28 B/L No. 91003047949747
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 1.09kg Amount 163.49
- Hs code 3004391900 Product tags medicaments
- Product description DO 32523185 DECLARACION(2-3) REG-50223411-20251126N DEL 2025-11-26, CON VISTO BUENO:VINVIMA-25-0165353, DEL 2025-11-26. FACTURA: 30209 FECHA: 2025-11-25 CANT (3) U PRODUCTO: LIOTIRONINA, NOMBRE COMERCIAL: LIOTHYRONINE SODIUM, PRINCIPIO ACTIVO: LIOTIRONINA, CONCENTRACION: 25 MCG, INDICACIONES TERAPEUTICAS: OTROS HIPOTIROIDISMOS ESPECIFICADOS, FORMA FARMACEUTICA: TABLETAS, TIPO DE EMPAQUE: FRASCO X 90 TABLETAS, USO: HUMANO, MARCA: SIGMA PHARMA LABORATORIES, LIOTHYRONINE SODIUM 25MCG (TAB 90) - SIGMA PHARMA/NOMBRE DEL PRINCIPIO ACTIVO: LIOTIRONINA CONCENTRACION DEL PRINCIPIO ACTIVO: 25 MCG NUMERO DE LOTE: 2412601. CANTIDAD PARA IMPORTAR (POR LOTE): 3 UNIDADES. FECHA DE VENCIMIENTO: 08/2029. NOMBRE COMPLETO DEL PACIENTE: LOZANO LOPEZ BRIGITTE MARCELA TIPO DEDOCUMENTO DE IDENTIFICACION: CODULA DE CIUDADANIA NUMERO DE IDENTIFICACION DEL PACIENTE: 29583959. TRATAMIENTO PARA 6 MESES. DOSIS: TOMAR 7 TABLETAS AL DIA. NOMBRE DEL LABORATORIO FABRICANTE: SIGMAPHARMA LABORATORIES PRESENTACION DEL PRODUCTO: FRASCO X 90 TAB Expand
- Trade date 2025/11/28 B/L No. 91003047949754
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 2.68kg Amount 401
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO 32523185 DECLARACION(3-3) REG-50222190-20251125N DEL 2025-11-25, CON VINVIMA-25-0164406 DEL 2025-11-25. FACTURA: 30210 FECHA: 2025-11-25 CANT (15) U PRODUCTO: CLORURO DE POTASIO, NOMBRE COMERCIAL: CLORURO DE POTASIO, PRINCIPIO ACTIVO: CLORURO DE POTASIO, CONCENTRACION: 1500 MG, INDICACIONES TERAPEUTICAS: SINDROME DE BARTTER, FORMA FARMACEUTICA: TABLETA, TIPO DE EMPAQUE: FRASCO X 100 TABLETAS, USO: HUMANO, MARCA: GRANULES PHARMACEUTICALS, POTASSIUM CHL 20 MEQ ER (100 TABS) - GRANULES PHARMACEUTICAL //PRINCIPIO ACTIVO: CLORURO DE POTASIO CONCENTRACION DEL PRINCIPIO ACTIVO: 1500 MG NUMERO DE LOTE: 7270258AA. CANTIDAD PARA IMPORTAR (POR LOTE): 9 FRASCOS. FECHA DE VENCIMIENTO: 12/2026. NOMBRE COMPLETO DEL PACIENTE: TOBON JARAMILLO MONICA. TIPO DE DOCUMENTODE IDENTIFICACION: CEDULA DE CIUDADANIA. NUMERO DE IDENTIFICACION DEL PACIENTE: 43617740. TIEMPO DEL TRATAMIENTO INDICADO EN LA AUTORIZACION: TRATAMIENTO PARA TRES (3) MESES. DOSIS: TOMAR TRES (3) TABLETAS VIA ORAL CADA 8 HORAS NOMBRE DEL LABORATORIO FABRICAN Expand
- Trade date 2025/11/28 B/L No. 91003047949731
- Suppliers pharmamed usa inc Buyers global services pharmaceutical s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 0.48kg Amount 71.98
- Hs code 3004391900 Product tags medicaments
- Product description DO 32523185 DECLARACION(1-3) REG-50222185-20251125N DEL 2025-11-25, CON VISTO BUENO:VINVIMA-25-0164416, DEL 2025-11-25. FACTURA: 30209 FECHA: 2025-11-25 CANT (1) U PRODUCTO: CYTOMEL, NOMBRE COMERCIAL: CYTOMEL, PRINCIPIO ACTIVO: LIOTIRONINA, CONCENTRACION:25 MCG, INDICACIONES TERAPEUTICAS: TRATAMIENTO PARA SEIS (6) MESES. DOSIS: TOMAR UNA (1) TABLETA VIA ORAL 3 VECES AL DIA, FORMA FARMACEUTICA: TABLETAS, TIPO DE EMPAQUE: FRASCOS X 100 TABLETAS, USO: HUMANO, MARCA: PFIZER, CYTOMEL 25 MCG TAB 100 - PFIZER // NOMBRE DEL PRINCIPIO ACTIVO: LIOTIRONINA CONCENTRACION DEL PRINCIPIO ACTIVO: 25 MCG NUMERO DE LOTE: 23T11 CANTIDAD PARA IMPORTAR (POR LOTE): 1 UNIDAD. FECHA DE VENCIMIENTO: 09/2026. NOMBRE COMPLETO DEL PACIENTE: GOMEZ DE BOTERO ISABEL MARIA IGNACIA TIPODE DOCUMENTO DE IDENTIFICACION: CODULA DE CIUDADANOA NUMERO DE IDENTIFICACION DEL PACIENTE: 21296941 TIEMPO DEL TRATAMIENTO INDICADO EN LA AUTORIZACION: TRATAMIENTO PARA SEIS (6) MESES. DOSIS: TOMAR UNA (1) TABLETA VIA ORAL TRES VECES AL DIA. NOMBRE DELLABORA Expand
- Trade date 2025/11/19 B/L No. 91003047773517
- Suppliers pharmamed usa inc Buyers international consulting network s.a.s.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 5.22kg Amount 651
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO: 11EJEBO11250038, NRO PEDIDO / ORDEN COMPRA:FACTURA NO 30069 GUIA FEDEX 885914943499 JOSE DANIEL / MARIA JOSE CORDERO POLO THERA 1510-1521, DECLARACION: 2/2; MERCANCIA NUEVA CON REGISTRO DE IMPORTACION NO REG-50148951-20250814N CON FECHA DE APROBACION14 DE AGOSTO DE 2025 Y VISTO BUENO INVIMA NO VINVIMA-25-0112898 CON FECHA DE APROBACION 13 DE AGOSTO DE 2025. EXENTA DE IVA SEGUN (ESTATUTO TRIBUTARIO) DECRETO EXTRAORDINARIO 624 DE 1989, MINISTERIO DE HACIENDA Y CREDITO PUBLICO ARTICULO 477. ; REGISTRODE IMPORTACION: 50148951, NOMBRE COMERCIAL: CLORURO DE POTASIO 20 MEQ K (1500 MG) TABLETA (GRANULES HARMACEUTICALS INCA), MARCA C: (GRANULES PHARMACEUTICALS INC)PRODUCTO: CLORURO DE POTASIO 20 MEQ K (1500 MG) TABLETA; NOMBRE COMERCIAL: CLORURO DE POTASIO20 MEQ K (1500 MG) TABLETA (GRANULES PHARMACEUTICALS INCA); PRINCIPIO ACTIVO: CLORURO DE POTASIO (EQ. A 20 MEQ) TABLETA 1500 MG; CONCENTRACION: CONCENTRACION: 1500 MG; INDICACIONES TERAPEUTICAS: TRASTORNOS RENALES TUBULOINTERSTICIALES EN OTRAS ENFERMEDADES CLASI Expand
Partners
Total 8- Rank Company Transactions Per Detail
- 1 global services pharmaceutical s.a.s. colombiabuyer,they trade on 2026-01-30 35 57.38% >
- 2 ripple pharmaceuticals ltd. kenyabuyer,they trade on 2025-12-24 8 13.11% >
- 3 suma activa s.a.s. colombiabuyer,they trade on 2026-01-28 8 13.11% >
- 4 international consulting network s.a.s. colombiabuyer,they trade on 2025-11-19 4 6.56% >
- 5 square pharmaceceuticals ltd. bangladeshsupplier,they trade on 2022-11-14 2 3.28% > +View All
Products
Total 2- Products Transactions Per Detail
-
equipped with fixed dose drug
3 75% > -
carbon agent
1 25% >
Hscode rank
Total 9- HSCode Name Transactions Per Detail
- HS 3004902900 3 75% >
- HS 3824999900 1 25% >
Trading Area
Total 4- Area Transactions Per Detail
- colombia 47 77.05% >
- kenya 8 13.11% >
- brazil 4 6.56% >
- bangladesh 2 3.28% >
pharmamed usa inc is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug，carbon agent.
According to the 52wmb.com global trade database, as of 2026-01-30, the company has completed 64 international trades,
with its main trading regions covering colombia，kenya,brazil etc.
The core products include HS3004902900，HS3824999900 etc,
and its main trading partners are global services pharmaceutical s.a.s.，ripple pharmaceuticals ltd.，suma activa s.a.s..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on pharmamed usa inc is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Hot companies :
u.o.t.trading co ltd.
Reference contact info
Email Hunting Tool